Sinonasal mucosal melanoma: Molecular profile and therapeutic implications from a series of 32 cases
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sinonasal mucosal melanoma: Molecular profile and therapeutic implications from a series of 32 cases
Authors
Keywords
-
Journal
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Volume 35, Issue 8, Pages 1066-1077
Publisher
Wiley
Online
2012-07-13
DOI
10.1002/hed.23079
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of Survival in Mucosal Melanoma of the Head and Neck
- (2011) Daniel Jethanamest et al. ANNALS OF SURGICAL ONCOLOGY
- Large-Scale Analysis of KIT Aberrations in Chinese Patients with Melanoma
- (2011) Y. Kong et al. CLINICAL CANCER RESEARCH
- A Melanoma Molecular Disease Model
- (2011) Smruti J. Vidwans et al. PLoS One
- Sensitivity of Fluorescence In Situ Hybridization for Melanoma Diagnosis Using RREB1, MYB, Cep6, and 11q13 Probes in Melanoma Subtypes
- (2010) Pedram Gerami et al. ARCHIVES OF DERMATOLOGY
- Postoperative Radiotherapy in Head and Neck Mucosal Melanoma
- (2010) Adil Benlyazid et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT
- (2010) D Handolias et al. BRITISH JOURNAL OF CANCER
- Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis
- (2010) J.-H. Lee et al. BRITISH JOURNAL OF DERMATOLOGY
- A phase 2 trial of dasatinib in advanced melanoma
- (2010) Harriet M. Kluger et al. CANCER
- Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib
- (2010) Joan Maurel et al. CANCER
- Vertical Targeting of the Phosphatidylinositol-3 Kinase Pathway as a Strategy for Treating Melanoma
- (2010) S. A. Aziz et al. CLINICAL CANCER RESEARCH
- Management of mucosal melanomas of the head and neck: did we make any progress?
- (2010) Mauricio A Moreno et al. Current Opinion in Otolaryngology & Head and Neck Surgery
- Outcome of sinonasal melanoma: Clinical experience and review of the literature
- (2010) Thomas N. Roth et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Proton Beam Therapy as a Nonsurgical Approach to Mucosal Melanoma of the Head and Neck: A Pilot Study
- (2010) Sadamoto Zenda et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma
- (2009) Pedram Gerami et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Mutations of the KIT gene and loss of heterozygosity of the PTEN region in a primary malignant melanoma arising from a mature cystic teratoma of the ovary
- (2009) Genshu Tate et al. CANCER GENETICS AND CYTOGENETICS
- Genetic Subgrouping of Melanoma Reveals New Opportunities for Targeted Therapy
- (2009) K. S.M. Smalley et al. CANCER RESEARCH
- Anal Mucosal Melanoma withKIT-Activating Mutation and Response to Imatinib Therapy – Case Report and Review of the Literature
- (2009) Imke Satzger et al. DERMATOLOGY
- Cutaneous Melanoma in Childhood and Adolescence Shows Frequent Loss of INK4A and Gain of KIT
- (2009) Maria Daniotti et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Understanding Melanoma Signaling Networks as the Basis for Molecular Targeted Therapy
- (2009) Keiran S.M. Smalley JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type
- (2009) Carlos A Torres-Cabala et al. MODERN PATHOLOGY
- Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates
- (2009) S. E. Woodman et al. MOLECULAR CANCER THERAPEUTICS
- Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors
- (2009) Bijay S. Jaiswal et al. PLoS One
- Esophageal melanomas harbor frequent NRAS mutations unlike melanomas of other mucosal sites
- (2009) Shigeki Sekine et al. VIRCHOWS ARCHIV
- Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas
- (2008) I Satzger et al. BRITISH JOURNAL OF CANCER
- Extracutaneous Malignant Melanomas
- (2008) Mahmoud R. Hussein CANCER INVESTIGATION
- Identification of a Novel Subgroup of Melanomas with KIT/Cyclin-Dependent Kinase-4 Overexpression
- (2008) K. S.M. Smalley et al. CANCER RESEARCH
- KIT Gene Mutations and Copy Number in Melanoma Subtypes
- (2008) C. Beadling et al. CLINICAL CANCER RESEARCH
- Clinical significance of oncogenicKITandPDGFRAmutations in gastrointestinal stromal tumours
- (2008) J Lasota et al. HISTOPATHOLOGY
- Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas
- (2008) Atsuko Ashida et al. INTERNATIONAL JOURNAL OF CANCER
- Mucosal Malignant Melanoma of the Head and Neck Treated by Carbon Ion Radiotherapy
- (2008) Takeshi Yanagi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Major Response to Imatinib Mesylate in KIT-Mutated Melanoma
- (2008) F. Stephen Hodi et al. JOURNAL OF CLINICAL ONCOLOGY
- CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations
- (2008) K S M Smalley et al. ONCOGENE
- Sinonasal melanoma: A clinicopathologic review of 61 cases
- (2008) Eileen H. Dauer et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation
- (2008) Jose Lutzky et al. Pigment Cell & Melanoma Research
- Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib
- (2008) Alfonso Quintás-Cardama et al. Nature clinical practice. Oncology
- What is the role of radiotherapy in the treatment of mucosal melanoma of the head and neck?
- (2007) Marco Krengli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started